“Heal me, O LORD, and I shall be healed; save me, and I shall be saved; for Thou art my praise.” Jeremiah 17:14 (The Israel Bible™)
Biokine focuses its research on “identifying novel molecular and cellular mechanisms that regulate tumor development and metastasis”, according to its website. With 14 years of clinical R&D under its belt, the company has developed a suite of unique approaches to fighting cancer. It has discovered and developed several molecules, and is conducting preclinical and clinical trials on them in-house.
BKT140/BL8040 targets a specific receptor, CXCR4, which is overexpressed in 70 percent of cancers and which is linked to the severity of the disease. The molecule is meant to inhibit the progression and spread of the cancer, both of which are dependent on CXCR4.
Professor Peled is a respected scientist, having published over 80 peer-reviewed papers in prestigious journals, like Blood, JCI and Science.
Read more at http://www.breakingisraelnews.com/63535/israeli-company-seeks-cure-for-cancer-health-science/#AerK3wVVaIC3fuQE.99